Use of Gadolinium Nanoparticles as Radiosensitizers for Brain Metastases: Results from the Phase 2 Multicentric Randomized Trial (NANORAD2)Camille Verry, Jacques Balosso, Antoine Leboucher et al.|International Journal of Radiation Oncology*Biology*Physics|2025Cited by 2